Dianthus Therapeutics
DNTH
DNTH
52 hedge funds and large institutions have $11M invested in Dianthus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
28% less funds holding
Funds holding: 72 → 52 (-20)
80% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 25
84% less capital invested
Capital invested by funds: $67.4M → $11M (-$56.4M)
Holders
52
Holding in Top 10
1
Calls
$10K
Puts
$2K
Top Buyers
| 1 | +$102K | |
| 2 | +$86.2K | |
| 3 | +$72.2K | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$47K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$25.7K |
Top Sellers
| 1 | -$9.5M | |
| 2 | -$5.06M | |
| 3 | -$3M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.84M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.81M |